Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Contact us
^
Login
BIOMARKER:
CD19 positive
i
Other names:
CD19, CD19 Molecule, B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12, Differentiation Antigen CD19, B-Lymphocyte Antigen CD19, CD19 Antigen, CVID3, B4
Entrez ID:
930
Related biomarkers:
Expression
CNA
Others
‹
›
Associations
(9)
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
CD19 positive
CD19 positive
Acute Lymphocytic Leukemia
ALL
blinatumomab
Sensitive: A1 - Approval
blinatumomab
Sensitive
:
A1
CD19 positive
CD19 positive
B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive: A1 - Approval
blinatumomab
Sensitive
:
A1
CD19 positive
CD19 positive
B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
CAR-T immunotherapy
Sensitive: C3 – Early Trials
CAR-T immunotherapy
Sensitive
:
C3
CD19 positive
CD19 positive
B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
CD19-STAR-T cells
Sensitive: C3 – Early Trials
CD19-STAR-T cells
Sensitive
:
C3
CD19 positive
CD19 positive
Small Lymphocytic Lymphoma
Small Lymphocytic Lymphoma
T-lymphocyte cell therapy
Sensitive: C4 – Case Studies
T-lymphocyte cell therapy
Sensitive
:
C4
CD19 positive
CD19 positive
Chronic Lymphocytic Leukemia
CLL
T-lymphocyte cell therapy
Sensitive: C4 – Case Studies
T-lymphocyte cell therapy
Sensitive
:
C4
CD19 positive
CD19 positive
Acute Lymphocytic Leukemia
ALL
FT596
Sensitive: D – Preclinical
FT596
Sensitive
:
D
CD19 positive
CD19 positive
Non-Hodgkin’s Lymphoma
NHL
ISIKOK-19
Sensitive: D – Preclinical
ISIKOK-19
Sensitive
:
D
CD19 positive
CD19 positive
B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
ISIKOK-19
Sensitive: D – Preclinical
ISIKOK-19
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
^
^
